发明名称 ANTIPLASMIN CLEAVING ENZYME
摘要 Human alpha<SUB>2</SUB>-antiplasmin (alpha<SUB>2</SUB>AP) is the major inhibitor of the proteolytic enzyme plasmin that digests fibrin. Two forms of alpha<SUB>2</SUB>AP circulate in human plasma: a 464-residue protein, which we have termed "pro"-form, or alpha<SUB>2</SUB>AP<SUB>pro</SUB>, and an N-terminally-shortened 452-residue "activated"-form, or alpha<SUB>2</SUB>AP<SUB>act</SUB>. The latter becomes crosslinked to fibrin by activated factor XIII about 5-fold more rapidly than alpha<SUB>2</SUB>AP<SUB>pro </SUB>and makes fibrin resistant to digestion by plasmin. A new human plasma proteinase has been identified herein that cleaves the Pro12-Asn13 bond of alpha<SUB>2</SUB>AP<SUB>pro </SUB>to yield alpha<SUB>2</SUB>AP<SUB>act</SUB>. This enzyme is identified herein as Antiplasmin Cleaving Enzyme (APCE).
申请公布号 EP1597360(A2) 申请公布日期 2005.11.23
申请号 EP20040709157 申请日期 2004.02.07
申请人 MCKEE, PATRICK A.;JACKSON, KENNETH W.;CHRISTIANSEN, VICTORIA J.;LEE, KYUNG N. 发明人 MCKEE, PATRICK A.;JACKSON, KENNETH W.;CHRISTIANSEN, VICTORIA J.;LEE, KYUNG N.
分类号 A61K38/00;C07K14/745;C07K14/81;C12N9/64;C12P21/06;C12Q1/37 主分类号 A61K38/00
代理机构 代理人
主权项
地址